| Bioactivity | Moxilubant hydrochloride (CGS-25019C hydrochloride) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant hydrochloride can be used for cancer research[1]. |
| Target | BLT1 |
| CAS | 146957-32-6 |
| Formula | C26H38ClN3O4 |
| Molar Mass | 492.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bhatt L, et al. Recent advances in clinical development of leukotriene B4 pathway drugs. Semin Immunol. 2017 Oct;33:65-73. |
Moxilubant hydrochloride
CAS: 146957-32-6 F: C26H38ClN3O4 W: 492.05
Moxilubant hydrochloride (CGS-25019C hydrochloride) is an orally active BLT1 antagonist which inhibits LTB4 signaling wi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.